Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 25, 2009Antimicrobial Agents and ChemotherapyOpen Access

In Vitro Activity of Colistin (Polymyxin E) against 3,480 Isolates of Gram-Negative Bacilli Obtained from Patients in Canadian Hospitals in the CANWARD Study, 2007-2008

View Full Paper
Ask AI
Bookmark
Share

Authors

AWAndrew WalktyMDMelanie DeCorbyKNKimberly A. Nichol

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Walkty et al. (2009) studied this question.

synapsesocial.com/papers/6aaf97ef456db84058de71aahttps://doi.org/10.1128/aac.00786-09
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A reassessment of the in-vitro activity of colistin sulphomethate sodium1997 · 139 citations
  2. 2Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections2005 · 1,752 citations
  3. 3Treatment of Multidrug‐Resistant<i>Acinetobacter baumannii</i>Ventilator‐Associated Pneumonia (VAP) with Intravenous Colistin: A Comparison with Imipenem‐Susceptible VAP2003 · 475 citations
  4. 4Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand2007 · 119 citations
  5. 5Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients2003 · 279 citations